Declines in different β2* nicotinic receptor populations in monkey striatum after nigrostriatal damage

Journal of Pharmacology and Experimental Therapeutics

Volumn 303, Issue 2, 2002, Pages 633-639

  Kulak, Jennifer M ^a   Musachio, John L ^b   Michael McIntosh, J ^a,c   Quik, Maryka ^c  

^a PARKINSON S INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 (2 AZETIDINYLMETHOXY)PYRIDINE; 5 IODO 3 (2 AZETIDINYLMETHOXY)PYRIDINE; ALPHA CONOTOXIN; BETA 2 NICOTINIC ACETYLCHOLINE RECEPTOR; CONOTOXIN; CYTISINE; EPIBATIDINE; IODINE 125; NEUROTOXIN; NICOTINE; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID ISOPROPYL ESTER; ALPHA CONOTOXIN MII; ALPHA-CONOTOXIN MII; AZETIDINE DERIVATIVE; COCAINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; NICOTINIC RECEPTOR BETA2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CAUDATE NUCLEUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG COMPETITION; DRUG RECEPTOR BINDING; LIGAND BINDING; MONKEY; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RADIOASSAY; STRIATONIGRAL DEGENERATION; ANIMAL; BRAIN LEVEL; CEBIDAE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; METABOLISM; NEOSTRIATUM; PARKINSON DISEASE; PHYSIOLOGY; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; AUTORADIOGRAPHY; AZETIDINES; BRAIN CHEMISTRY; CAUDATE NUCLEUS; COCAINE; CONOTOXINS; NEOSTRIATUM; PARKINSON DISEASE, SECONDARY; PUTAMEN; RADIOLIGAND ASSAY; RECEPTORS, NICOTINIC; SAIMIRI; SUBSTANTIA NIGRA;

EID: 0036826866     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.039347     Document Type: Article

References (40)

1. Ball J (2001) Current advances in Parkinson's disease. Trends Neurosci 24:367-369.
2. Cartier GE, Yoshikami D, Gray WR, Luo S, Olivera BM, and McIntosh JM (1996) A new a-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J Biol Chem 271:7522-7528.
3. Champtiaux N, Han Z-Y, Bessis A, Rossi FM, Zoli M, Marubio L, McIntosh JM, and Changeux J-P (2002) Distribution and pharmacology of α6-containing nicotinic acetylcholine receptors analyzed with mutant mice. J Neurosci 22:1208-1217.
4. Changeux JP, Bertrand D, Corringer PJ, Dehaene S, Edelstein S, Lena C, Le Novere N, Marubio L, Picciotto M, and Zoli M (1998) Brain nicotinic receptors: Structure and regulation, role in learning and reinforcement. Brain Res Brain Res Rev 26:198-216.
5. Court JA, Martin-Ruiz C, Graham A, and Perry E (2000) Nicotinic receptors in human brain: Topography and pathology. J Chem Neuroanat 20:281-298.
6. Emmers R and Akert K (1963) A Stereotaxic Atlas of the Brain of the Squirrel Monkey Saimiri Sciureus. University of Wisconsin Press, Madison, WI.
7. 123I]5-I-A-85380 in healthy human subjects. Eur J Nucl Med 29:183-190.
8. Gotti C, Fornasari D, and Clementi F (1997) Human neuronal nicotinic receptors. Prog Neurobiol 53:199-237.
9. Grady SR, Meinerz NM, Cao J, Reynolds AM, Picciotto MR, Changeux JP, McIntosh JM, Marks MJ, and Collins AC (2001) Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: A function mediated by a different nAChR than dopamine release from striatum. J Neurochem 76:258-268.
10. Han ZY, Le Novere N, Zoli M, Hill JA Jr, Champtiaux N, and Changeux JP (2000) Localization of nAChR subunit mRNAs in the brain of Macaca mulatta. Eur J Neurosci 12:3664-3674.
11. Jones S, Sudweeks S, and Yakel JL (1999) Nicotinic receptors in the brain: Correlating physiology with function. Trends Neurosci 22:555-561.
12. Kelton MC, Kahn HJ, Conrath CL, and Newhouse PA (2000) The effects of nicotine on Parkinson's disease. Brain Cogn 43:274-282.
13. Kulak JM, McIntosh JM, and Quik M (2002a) Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2 3,6-tetrahydropyridine treatment is due to a decline in α-conotoxin MII sites. Mol Pharmacol 61:230-238.
14. Kulak JM, Nguyen TA, Yoshikami D, Olivera BM, and McIntosh JM (1997) α-Conotoxin MII blocks nicotine-stimulated dopamine release from rat striatal synaptosomes. J Neurosci 17:5263-5270.
15. Kulak JM, Sum J, Musachio JL, McIntosh JM, and Quik M (2002b) Iodo-A-85380 binds to α-conotoxin MII-sensitive nicotinic receptors as well as α4β2* subtypes. J Neurochem 81:403-406.
16. Lang AE and Lozano AM (1998) Parkinson's disease. First of two parts. N Engl J Med 339:1044-1053.
17. Le Novere N, Zoli M, and Changeux J-P (1996) Neuronal nicotinic receptor α6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur J Neurosci 8:2428-2439.
18. Luetje CW and Patrick J (1991) Both α- and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J Neurosci 11:837-845.
19. Lukas RJ, Changeux JP, Le Novere N, Albuquerque EX, Balfour DJ, Berg DK, Bertrand D, Chiappinelli VA, Clarke PB, Collins AC, et al. (1999) International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev 51:397-401.
20. MacDermott AB, Role LW, and Siegelbaum SA (1999) Presynaptic ionotropic receptors and the control of transmitter release. Annu Rev Neurosci 22:443-485.
21. McIntosh JM, Santos AD, and Olivera BM (1999) Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. Annu Rev Biochem 68:59-88.
22. Morens DM, Grandinetti A, Reed D, White LR, and Ross GW (1995) Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue? Neurology 45:1041-1051.
23. Mukhin AG, Gundisch D, Horti AG, Koren AO, Tamagnan G, Kimes AS, Chambers J, Vaupel DB, King SL, Picciotto MR, et al. (2000) 5-Iodo-A-85380, an α4β2 subtype-selective ligand for nicotinic acetylcholine receptors. Mol Pharmacol 57:642-649.
24. Musachio JL, Scheffel U, Finley PA, Zhan Y, Mochizuki T, Wagner HN Jr, and Dannals RF (1998) 5-[I-125/123]Iodo-3(2(S)-azetidinylmethoxy)pyridine, a radio-iodinated analog of A-85380 for in vivo studies of central nicotinic acetylcholine receptors. Life Sci 62:351-357.
25. Parker MJ, Beck A, and Luetje CW (1998) Neuronal nicotinic receptor β2 and β4 subunits confer large differences in agonist binding affinity. Mol Pharmacol 54:1132-1139.
26. Quik M and Jeyarasasingam G (2000) Nicotinic receptors and Parkinson's disease. Eur J Pharmacol 393:223-230.
27. Quik M, Polonskaya Y, Gillespie A, Jakowec M, Lloyd GK, and Langston JW (2000a) Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization. J Comp Neurol 425:58-69.
28. Quik M, Polonskaya Y, Gillespie A, Lloyd GK, and Langston JW (2000b) Differential alterations in nicotinic receptor α6 and β3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration. Neuroscience 100:63-72.
29. 125I-α-conotoxin MII binding sites to nigrostriatal damage in monkey. J Neurosci 21:5494-5500.
30. Sargent PB (1993) The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 16:403-443.
31. Schwartz RD, Lehmann J, and Kellar KJ (1984) Presynaptic nicotinic cholinergic receptors labeled by [3H]acetylcholine on catecholamine and serotonin axons in brain. J Neurochem 42:1495-1498.
32. Smith Y and Kieval JZ (2000) Anatomy of the dopamine system in the basal ganglia. Trends Neurosci 23:S28-S33.
33. Sullivan JP, Donnelly-Roberts D, Briggs CA, Anderson DJ, Gopalakrishnan M, Piattoni-Kaplan M, Campbell JE, McKenna DG, Molinari E, Hettinger AM, et al. (1996) A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: In vitro pharmacological properties of a novel, high affinity α4β2 nicotinic acetylcholine receptor ligand. Neuropharmacology 35:725-734.
34. Vaupel DB, Koren AO, and Tella S (2001) Radiotracers for imaging nicotinic acetylcholine receptors (nAChRs): Electrecardiogram effects of 5-I-A-85380 (5IA) and 2-F-A-85380 (2FA) and nicotine. Soc Neurosci Abstr 27:240.2.
35. Villemange V, Musachio J and Scheffel U (1998) Nicotine and related compounds as PET and SPECT ligands, in Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities (Arneric S and Brioni J, eds) pp 235-249, Wiley-Liss, New York.
36. Whiteaker P, Marks MJ, McIntosh JM, Picciotto MR, Changeux J-P, and Collins AC (1998) Location and composition of α-conotoxin MII binding nicotinic receptors in mouse brain. Soc Neurosci Abstr 24:332.8.
37. Whiteaker P, Peterson CG, Xu W, McIntosh JM, Paylor R, Beaudet AL, Collins AC, and Marks MJ (2002) Involvement of the α3 subunit in central nicotinic binding populations. J Neurosci 22:2522-2529.
38. 125I 5-iodo-A-85380. J Nucl Med 42:142P.
39. Wonnacott S (1997) Presynaptic nicotinic ACh receptors. Trends Neurosci 20:92-98.
40. Zhou FM, Liang Y, and Dani JA (2001) Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci 4:1224-1229.